Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 1/2018

01-03-2018 | Special Article

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—CME information

Authors: Matti Aapro, Mark Clemons, Lee Schwartzberg, David Warr

Published in: Supportive Care in Cancer | Special Issue 1/2018

Login to get access

Excerpt

Release Date: March 15, 2018 Expiration Date: March 15, 2019 …
Metadata
Title
Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—CME information
Authors
Matti Aapro
Mark Clemons
Lee Schwartzberg
David Warr
Publication date
01-03-2018
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue Special Issue 1/2018
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4122-4

Other articles of this Special Issue 1/2018

Supportive Care in Cancer 1/2018 Go to the issue

Special Article

Getting it right the first time: recent progress in optimizing antiemetic usage

Special Article

Guidelines versus individualized care for the management of CINV

Special Article

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—concluding thoughts

Special Article

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting—introduction

Special Article

CINV: still troubling patients after all these years

Special Article

Bringing it all together in the treatment of CINV: application of current knowledge into routine clinical practice
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits